Skip to main content

Why is Angel Broking trading at a discount in grey market ahead of listing?

Source - Moneycontrol.com

Experts feel the rising competition in the broking industry and muted response to the IPO with nearly 4 times subscription could be the reasons behind Angel Broking trading at a discount.

Retail broking house Angel Broking is the only IPO that slipped into discount ahead of its listing in the year 2020.

In fact, it had started on a strong note with a premium of around Rs 100 over IPO price of Rs 306 per share especially after the announcement of the price band. However, the increasing market volatility (which could one of the reasons),  it gradually started losing its tempo and around issue closing, the premium dropped to Rs 15-20.

The decline did not stop there. It further dipped and turned into discount around the announcement of the basis of allotment. So far, among the listed stocks in the year 2020, no one has reported this sort of weak performance though there has been a decline in premium.

Experts feel the rising competition in the broking industry and muted response to the IPO with nearly 4 times subscription could be the reasons behind Angel Broking trading at a discount.

Angel Broking, one of the largest retail broking houses on the basis of active clients on NSE, was the first broking company to come out with IPO plans in the last ten years. It is going to list its shares on bourses on October 5 and the issue price has been fixed at Rs 306 per share.



"Reason might lie in fundamentals as full-service brokers have tough competition faced by discount brokers. Apart from this, the response was on the muted side compared to recent IPOs," Gaurav Garg, Head of Research at CapitalVia Global Research told Moneycontrol.

Manali Bhatia, Head-Research at Rudra Shares & Stock Brokers also said the broking industry has become highly competitive. "Besides, the entry of discount broking players could pose a threat in the growth story going ahead."

She further said Angel Broking is heavily litigated with issues and punched with notices. Earlier, SEBI had put a trading ban on one of its promoters Lalit T Thakkar for two years.

Considering the above-stated factors, she believes the stock could correct more going ahead.

Angel Broking raised Rs 600 crore via public issue which consisted of a fresh issue of Rs 300 crore and an offer for sale of Rs 300 crore by promoters and investors.

The company provides broking and allied services through online and digital platforms, and network of over 11,000 authorised persons as of June 2020. The company managed Rs 13,254 crore in client assets and over 21.5 lakh operational broking accounts as of June 2020.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more